How many employees does Zevra Therapeutics, Inc. have?

Zevra Therapeutics, Inc. reported 61 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 9, 2026. That is up 3.4% from a year earlier.

What is Zevra Therapeutics, Inc.'s revenue per employee?

Zevra Therapeutics, Inc. brought in $106M of revenue in fiscal Dec 2025, which is $1.75M per employee. That ranks 13 of 108 companies we track in Biotechnology, where the median is $459K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Zevra Therapeutics, Inc. employees and revenue per employee

ZVRA · Biotechnology · $673M market cap

Zevra Therapeutics, Inc. had 61 employees at the end of fiscal Dec 2025, up 3.4% from a year earlier. Revenue for the year was $106M, up 350.9% from a year earlier, or $1.75M per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

+3.4% YoY

Revenue

$106M

+350.9% YoY

Revenue / employee

$1.75M

Peer median $459K

Rank in industry

13 of 108

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2023

Hover a year for the numbers.

ZVRA employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	61	$106M	$1.75M	+3.4%	+350.9%
Dec 2024	59	$23.6M	$400K	-9.2%	-14.0%
Dec 2023	65	$27.5M	$422K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Zevra Therapeutics, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
ZVRA Zevra Therapeutics, Inc.	61	$106M	$1.75M	Efficient growth
AGEN Agenus Inc.	81	$114M	$1.41M	Leaner
GLUE Monte Rosa Therapeutics, Inc.	150	$124M	$824K	Efficient growth
XNCR Xencor, Inc.	260	$126M	$483K	Efficient growth
ZYME Zymeworks Inc.	264	$106M	$401K	Leaner
URGN UroGen Pharma Ltd.	291	$110M	$377K	Hiring ahead
GYRE Gyre Therapeutics, Inc.	618	$117M	$189K	Efficient growth
IBRX ImmunityBio, Inc.	691	$113M	$164K	Efficient growth
CYTK Cytokinetics, Incorporated	673	$88.0M	$131K	Efficient growth

Every Healthcare company

Questions about Zevra Therapeutics, Inc.

How many employees does Zevra Therapeutics, Inc. have?: Zevra Therapeutics, Inc. reported 61 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 9, 2026. That is up 3.4% from a year earlier.
What is Zevra Therapeutics, Inc.'s revenue per employee?: Zevra Therapeutics, Inc. brought in $106M of revenue in fiscal Dec 2025, which is $1.75M per employee. That ranks 13 of 108 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare ZVRA with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Zevra Therapeutics, Inc.'s annual reports (Form 10-K), latest filed March 9, 2026. This is data, not a recommendation to buy or sell ZVRA.